The effects of Allium cepa L. (onion) and its active constituents on metabolic syndrome: A review

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 320

فایل این مقاله در 14 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-24-1_002

تاریخ نمایه سازی: 19 دی 1399

چکیده مقاله:

Metabolic syndrome as a clustering disorder includes excess abdominal fat distribution, abnormal insulin and glucose metabolism, disturbed blood lipids, pro-inflammatory state, and hypertension. Regarding to the adverse effects of synthetic medicines, the identification of appropriate healthcare approaches, such as herbal medicines, with fewer side effects is more favorable. Allium cepa L. (onion) is a culinary and medicinal herb belonging to the family of Amaryllidaceae. Flavonoids such as quercetin and kaempferol, alk(en)yl cysteine sulfoxides including S-methyl cysteine sulfoxide and S-propyl cysteine sulfoxide, cycloalliin, thiosulfinates, and sulfides are main compounds existing in the plant. A. cepa and its pharmacologically active constituents display broad-spectrum activities including anti-oxidant, anti-inflammatory, lipid-modifying, anti-obesity, antihypertensive, and antidiabetic effects. Our objective in this review was to find out the role of A. cepa and its bioactive phytochemicals as cardiovascular protective agents in different metabolic syndrome risk factors, including hyperlipidemia, high blood glucose, obesity, and hypertension.

نویسندگان

Amin Galavi

School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Hosseinzadeh

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Bibi Marjan Razavi

Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin ...
  • 2. Mottillo S, Filion KB, Genest J, Joseph L, Pilote ...
  • 3. GBD 2017 Causes of Death Collaborators. Global, regional, and ...
  • 4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel ...
  • 5. Ekor M. The growing use of herbal medicines: issues ...
  • 6. Teshika JD, Zakariyyah AM, Zaynab T, Zengin G, Rengasamy ...
  • 7. Upadhyay RK. Nutraceutical, pharmaceutical and therapeutic uses of Allium ...
  • 8. Ahmed N, Mahmood A, Ashraf A, Bano A, Tahir ...
  • 9. Josabad Alonso-Castro A, Jose Maldonado-Miranda J, Zarate-Martinez A, Jacobo-Salcedo ...
  • 10. Ayyanar M, Ignacimuthu S. Ethnobotanical survey of medicinal plants ...
  • 11. Prakash D, Singh BN, Upadhyay G. Anti-oxidant and free ...
  • 12. Breu W. Allium cepa L. (onion) Part 1: Chemistry ...
  • 13. Lee B, Jung JH, Kim HS. Assessment of red ...
  • 14. Ren KW, Li YH, Wu G, Ren JZ, Lu ...
  • 15. Wang R, Yang L, Li S, Ye D, Yang ...
  • 16. Draelos ZD. The ability of onion extract gel to ...
  • 17. Peng Z, Gong X, Yang Y, Huang L, Zhang ...
  • 18. Ro JY, Ryu JH, Park HJ, Cho HJ. Onion ...
  • 19. Lee SM, Moon J, Chung JH, Cha YJ, Shin ...
  • 20. Kumar VP, Venkatesh YP. Alleviation of cyclophosphamide-induced immunosuppression in ...
  • 21. Khajah MA, Orabi KY, Hawai S, Sary HG, El-Hashim ...
  • 22. Reddy RRL, Srinivasan K. Dietary fenugreek and onion attenuate ...
  • 23. Singh T, Goel RK. Neuroprotective effect of Allium cepa ...
  • 24. Kim JH. Antibacterial action of onion (Allium cepa L.) ...
  • 25. Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, Moghadasi B, Ghajari ...
  • 26. Kaiser P, Youssouf MS, Tasduq SA, Singh S, Sharma ...
  • 27. Oliveira TT, Campos KM, Cerqueira-Lima AT, Cana Brasil Carneiro ...
  • 28. Haidari F, Rashidi MR, Keshavarz SA, Mahboob SA, Eshraghian ...
  • 29. Samad N, Saleem A. Administration of Allium cepa L. ...
  • 30. Jain S, Buttar HS, Chintameneni M, Kaur G. Prevention ...
  • 31. Tang GY, Meng X, Li Y, Zhao CN, Liu ...
  • 32. Thomson M, Alnaqeeb MA, Bordia T, Al-Hassan JM, Afzal ...
  • 33. Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Asghari-Jafarabadi M. Effects ...
  • 34. Kim J, Cha YJ, Lee KH, Park E. Effect ...
  • 35. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular ...
  • 36. Srinivasan K. Dietary spices as beneficial modulators of lipid ...
  • 37. Han SY, Hu Y, Anno T, Yanagita T. S-propyl ...
  • 38. Lee YG, Cho J, Hwang EJ, Jeon T, Moon ...
  • 39. Sun L, Li E, Wang F, Wang T, Qin ...
  • 40. Arteaga E, Villaseca P, Rojas A, Marshall G, Bianchi ...
  • 41. Bordia A, Arora SK, Kothari LK, Jain KC, Rathore ...
  • 42. Vidyavati HG, Manjunatha H, Hemavathy J, Srinivasan K. Hypolipidemic ...
  • 43. Kang HJ, Pichiah BT, Abinaya RV, Sohn HS, Cha ...
  • 44. Jaiswal N, Rizvi SI. Onion extract (Allium cepa L.), ...
  • 45. De Boer VCJ, Van Schothorst EM, Dihal AA, Van ...
  • 46. Yanagita T, Han S, Wang YM, Tsuruta Y, Anno ...
  • 47. Kumari K, Augusti KT. Lipid lowering effect of S-methyl ...
  • 48. Emamat H, Foroughi F, Eini-Zinab H, Hekmatdoost A. The ...
  • 49. Emamat H, Foroughi F, Eini-Zinab H, Taghizadeh M, Rismanchi ...
  • 50. Lu TM, Chiu HF, Shen YC, Chung CC, Venkatakrishnan ...
  • 51. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass ...
  • 52. Joo JK, Lee KS. Pharmacotherapy for obesity. J Menopausal ...
  • 53. Marrelli M, Amodeo V, Statti G, Conforti F. Biological ...
  • 54. Williams DJ, Edwards D, Hamernig I, Jian L, James ...
  • 55. Funakoshi T, Kanzaki N, Otsuka Y, Izumo T, Shibata ...
  • 56. Bae CR, Park YK, Cha YS. Quercetin-rich onion peel ...
  • 57. Seo MJ, Lee YJ, Hwang JH, Kim KJ, Lee ...
  • 58. Eseberri I, Miranda J, Lasa A, Churruca I, Portillo ...
  • 59. Yoshinari O, Shiojima Y, Igarashi K. Anti-Obesity Effects of ...
  • 60. Forney LA, Lenard NR, Stewart LK, Henagan TM. Dietary ...
  • 61. Pangeni R, Kang SW, Oak M, Park EY, Park ...
  • 62. Cypess AM, Lehman S, Williams G, Tal I, Rodman ...
  • 63. Lee SG, Parks JS, Kang HW. Quercetin, a functional ...
  • 64. Lee JS, Cha YJ, Lee KH, Yim JE. Onion ...
  • 65. Kim KA, Yim JE. The effect of onion peel ...
  • 66. Blacher J, Levy BI, Mourad JJ, Safar ME, Bakris ...
  • 67. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender ...
  • 68. Aslam M, Ahmad M, Mobasher F. Efficacy and tolerability ...
  • 69. Chen ZY, Peng C, Jiao R, Wong YM, Yang ...
  • 70. Oboh G, Ademiluyi AO, Agunloye OM, Ademosun AO, Ogunsakin ...
  • 71. Muhammad SA, Fatima N. In silico analysis and molecular ...
  • 72. Monori-Kiss A, Monos E, Nádasy GL. Quantitative analysis of ...
  • 73. Lodi F, Jimenez R, Moreno L, Kroon PA, Needs ...
  • 74. Brankovic S, Radenkovic M, Kitic D, Veljkovic S, Ivetic ...
  • 75. Naseri MKG, Arabian M, Badavi M, Ahangarpour A. Vasorelaxant ...
  • 76. Kawamoto E, Sakai Y, Okamura Y, Yamamoto Y. Effects ...
  • 77. Sakai Y, Murakami T, Yamamoto Y. Antihypertensive effects of ...
  • 78. Kivirantat J, Huovinen K, Seppänen‐Laakso T, Hiltunen R, Karppanen ...
  • 79. Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig ...
  • 80. Perez A, Gonzalez-Manzano S, Jimenez R, Perez-Abud R, Haro ...
  • 81. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons ...
  • 82. Kalus U, Pindur G, Jung F, Mayer B, Radtke ...
  • 83. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller ...
  • 84. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes ...
  • 85. American Diabetes Association. Microvascular complications and foot care: standards ...
  • 86. Kim HY, Kim K. Protein glycation inhibitory and antioxidative ...
  • 87. Jaiswal N, Rizvi SI. Amylase inhibitory and metal chelating ...
  • 88. Kim SH, Jo SH, Kwon YI, Hwang JK. Effects ...
  • 89. Schulze C, Bangert A, Schwanck B, Vollert H, Blaschek ...
  • 90. Gautam S, Pal S, Maurya R, Srivastava AK. Ethanolic ...
  • 91. Augusti KT. Effect of alloxan diabetes of allyl propyl ...
  • 92. Augusti KT, Roy VCM, Semple M. Effect of allyl ...
  • 93. Jain RC, Vyas CR. Letter: Hypoglycaemia action of onion ...
  • 94. Karawya MS, Abdel Wahab SM, El-Olemy MM, Farrag NM. ...
  • 95. Kumari K, Augusti KT. Antidiabetic effects of s-methylcysteine sulfoxide ...
  • 96. Ikechukwu OJ, Ifeanyi OS. The Antidiabetic effects of the ...
  • 97. Kook S, Kim GH, Choi K. The antidiabetic effect ...
  • 98. Devarshi PP, Jones AD, Taylor EM, Stefanska B, Henagan ...
  • 99. Snyder SM, Zhao B, Luo T, Kaiser C, Cavender ...
  • 100. Kaur G, Invally M, Chintamaneni M. Influence of piperine ...
  • 101. Al-Malki AL. inhibition of alpha-glucosidase by thiosulfinate as a ...
  • 102. Thomas S, Senthilkumar GP, Sivaraman K, Bobby Z, Paneerselvam ...
  • 103. Gomes IBS, Porto ML, Santos MCLFS, Campagnaro BP, Pereira ...
  • 104. Jung YS, Kim MH, Lee SH, Baik EJ, Park ...
  • 105. Fallah V, Mahabadi JA, Mahabadi MY, Kashani HH, Nikzad ...
  • 106. Bhanot A, Shri R. A comparative profile of methanol ...
  • 107. Jafarpour-Sadegh F, Montazeri V, Adili A, Esfehani A, Rashidi ...
  • 108. Taj Eldin IM, Ahmed EM, Elwahab HMA. Preliminary study ...
  • 109. Hoffman R, Ranjbar G, Madden AM. Inhibition of the ...
  • 110. Lee SM, Moon J, Cho Y, Chung JH, Shin ...
  • 111. Jung H, Wee JH, Kim K, Sung H, Shin ...
  • 112. Lata S, Saxena KK, Bhasin V, Saxena RS, Kumar ...
  • 113. Guan L, Chung HY, Su YL, Jiao R, Peng ...
  • 114. Sikder K, Das N, Kesh SB, Dey S. Quercetin ...
  • 115. Moon J, Do HJ, Kim OY, Shin MJ. Antiobesity ...
  • 116. Henagan TM, Cefalu WT, Ribnicky DM, Noland RC, Dunville ...
  • 117. Arias N, Picó C, Teresa Macarulla M, Oliver P, ...
  • 118. Vazquez-Prieto MA, Rodriguez Lanzi C, Lembo C, Galmarini CR, ...
  • 119. Gonzalez-Pena D, Angulo J, Vallejo S, Colina-Coca C, de ...
  • 120. Jalili T, Carlstrom J, Kim S, Freeman D, Jin ...
  • 121. Wu HR, Xu BJ. Inhibitory effects of onion against ...
  • 122. Ozougwu JC. Anti-diabetic effects of Allium cepa (onions) aqueous ...
  • 123. Babu PS, Srinivasan K. Influence of dietary capsaicin and ...
  • 124. El-Soud NA, Khalil M. Antioxidative effects of Allium cepa ...
  • 125. Ogunmodede OS, Saalu LC, Ogunlade B, Akunna GG, Oyewopo ...
  • 126. Jung JY, Lim Y, Moon MS, Kim JY, Kwon ...
  • 127. Arias N, MacArulla MT, Aguirre L, Martínez-Castaño MG, Portillo ...
  • 128. Anhê GF, Okamoto MM, Kinote A, Sollon C, Lellis-Santos ...
  • 129. Shetty AK, Rashmi R, Rajan MGR, Sambaiah K, Salimath ...
  • 130. Khaki A, Fathiazad F, Ahmadi-Ashtiani HR, Rezazadeh S, Rastegar ...
  • 131. G PS, Thomas S, K S, Sankar P, Bobby ...
  • 132. Choi EY, Lee H, Woo JS, Jang HH, Hwang ...
  • 133. Khorshidi M, Moini A, Alipoor E, Rezvan N, Gorgani-Firuzjaee ...
  • 134. Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig ...
  • 135. Nishimura M, Muro T, Kobori M, Nishihira J. Effect ...
  • 136. Bruell V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig ...
  • 137. Lee KH, Park E, Lee HJ, Kim MO, Cha ...
  • 138. Rezvan N, Moini A, Gorgani-Firuzjaee S, Hosseinzadeh-Attar MJ. Oral ...
  • نمایش کامل مراجع